FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to hepatology and transplantology. Patient, in addition to the MELD-Na index, takes into account the age, the nature of hepatic impairment, blood leukocyte count, presence of portal vein thrombosis. Each score is assigned with corresponding points: if the patient's age is less than or equal to 43 years, 1 point is scored, while the patient's age from 44 to 51 years old - 2 points, if patient aged 52 to 57 years old - 3 points, if the patient's age is more than or equal to 58 years, 4 points are scored. If the patient suffers chronic hepatic insufficiency, 1 point is scored, if acute hepatic impairment - 2 points. If the MELD-Na index is less than or equal to 17, 1 point is awarded, while the MELD-Na index from 18 to 20 shows 2 points, while the MELD-Na index from 21 to 24 shows 3 points, while the MELD-Na index is more than or equal to 25 - 4 points. If leukocyte level is more than or equal to 3.8×109/l is 1 point, with leukocyte level of 3.2 to 3.7×109/l - 2 points, with leukocyte level from 2.8 to 3.1×109/l - 3 points, with leukocyte level less than or equal to 2.7×109/l - 4 points. If portal vein thrombosis is present, 1 point is scored, if absent - 0 points. Obtained points are substituted into original formula and index value is calculated, which enables to determine probability of death in patient waiting for liver transplantation for one year.
EFFECT: method provides higher accuracy of assessing the risk of unfavourable outcome (death) of a patient for one year, enables solving the question of assessing the effectiveness of treatment and priority distribution of donor organs.
1 cl, 3 dwg, 7 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING THE RISK OF DEATH IN LIVER CIRRHOSIS | 2021 |
|
RU2761729C1 |
METHOD FOR PREDICTION OF FAILURE IN PATIENTS WITH VIRAL AND ALCOHOLIC HEATOCIRRHOSIS | 2008 |
|
RU2381748C1 |
METHOD FOR PREDICTION OF FATAL OUTCOME IN PATIENTS SUFFERING FROM VIRAL AND ALCOHOLIC HEPATIC CIRRHOSIS | 2008 |
|
RU2373533C1 |
METHOD FOR THREE-STAGE MINIMALLY INVASIVE TREATMENT OF COMPLICATIONS OF HEPATIC CIRRHOSIS | 2023 |
|
RU2816786C1 |
METHOD FOR PREDICTION OF FATAL OUTCOMES IN PATIENTS SUFFERING VIRAL OR ALCOHOLIC CIRRHOSIS | 2011 |
|
RU2465818C1 |
METHOD FOR QUANTITATIVE ESTIMATION OF SEVERITY OF ALCOHOLIC CIRRHOSIS AND PREDICTION OF FATALITY DURING CURRENT HOSPITALISATION | 2020 |
|
RU2747771C1 |
METHOD OF PREDICTING DEVELOPMENT OF CRITICAL HEPATIC FAILURE BASING ON SELENIUM LEVEL IN SERUM | 2014 |
|
RU2549963C1 |
METHOD OF ESTIMATING RISK OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT SURGERY IN PATIENTS WITH PORTAL HYPERTENSION OF CIRRHOTIC GENESIS | 2011 |
|
RU2492479C2 |
METHOD OF PREDICTING AN INCREASED RISK OF DECOMPENSATION OF LIVER CIRRHOSIS OR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH LIVER CIRRHOSIS IN THE OUTCOME OF CHRONIC HEPATITIS C AFTER ACHIEVING A SUSTAINED VIROLOGIC RESPONSE | 2022 |
|
RU2800251C1 |
METHOD FOR REGENERATIVE CELL THERAPY FOR TREATING HEPATOCELLULAR INSUFFICIENCY IN LIVER CIRRHOSIS | 2023 |
|
RU2822653C1 |
Authors
Dates
2020-12-01—Published
2020-04-03—Filed